Mathé G, Amiel J L, Schwarzenberg L, Choay J, Trolard P, Schneider M, Hayat M, Schlumberger J R, Jasmin C
Br Med J. 1970 Apr 18;2(5702):131-6. doi: 10.1136/bmj.2.5702.131.
Allogeneic bone marrow grafts carried out after previous administration of antilymphocytic serum alone were attempted in 16 patients. Of these, six had acute myeloblastic leukaemia, four acute lymphoblastic leukaemia, and one a blast cell crisis in polycythaemia vera. Ten of these patients were in an overt phase of the disease and resistant to chemotherapy, while nine had complete agranulocytosis. In five of these patients erythrocyte and leucocyte antigenic markers demonstrated the establishment of the graft. One patient had thalassaemia major, and four others had aplasia of the bone marrow, in one case due to chloramphenicol poisoning and in another to virus hepatitis. The grafts were successful in the last two patients and transformed their clinical condition.No signs of early acute secondary disease were noted in any of the patients, either when the donor had been given antilymphocytic serum or when he was untreated. The grafts had no adoptive immunotherapeutic effect on the acute leukaemia. These observations have clearly shown that antilymphocytic serum has an immunosuppressive effect in man when it is used alone.
对16例患者尝试进行了在先前单独给予抗淋巴细胞血清后进行的同种异体骨髓移植。其中,6例患有急性髓细胞白血病,4例患有急性淋巴细胞白血病,1例患有真性红细胞增多症的原始细胞危象。这些患者中有10例处于疾病的明显阶段且对化疗耐药,而9例有完全性粒细胞缺乏症。其中5例患者的红细胞和白细胞抗原标志物表明移植已成功建立。1例患者患有重型地中海贫血,另外4例患有骨髓发育不全,1例是由于氯霉素中毒,另1例是由于病毒性肝炎。最后2例患者的移植成功并改善了他们的临床状况。在任何患者中均未观察到早期急性继发性疾病的迹象,无论是供体接受了抗淋巴细胞血清还是未接受治疗。这些移植对急性白血病没有过继免疫治疗作用。这些观察结果清楚地表明,抗淋巴细胞血清单独使用时在人体中具有免疫抑制作用。